Submit an Abstract

​​​Abstract submission is now closed.

Abstract Submission Deadline: January 20, 2016

Abstract Notification: Beginning of March 2016


Please note that there will be no extension for abstract submission and no late-breaking abstract submission.

ABSTRACT PREPARATION GUIDELINES

ESPID 2016 is pleased to announce its new abstract submission system for the upcoming Meeting in Brighton!

1. ​​​Topic Selection:

You will first need to select your abstract topic. To view the ESPID 2016 abstract topics, please click here.

Please choose one of the topics for your abstract. The categories overlap – choose the one that you think fits best. 

​Categories preceded by the letter "S" map to one of the PLENARY SESSIONS OR themed symposia of the Meeting. If you choose one of these categories your abstract MAY be considered for oral presentation at the relevant symposium.

************************************************************************************************

NEW! Meet the Professor Case Submission via the abstract submission system.

The ESPID “Meet the Professor Sessions" at the 2016 Meeting will consist of interactive case-based discussions each with a coordinator who will select and present cases and either one or two expert discussants. 

Should you wish to have your abstract considered as an educational or controversial case in one of these sessions, please select the Theme: Clinical Education: A case or Case Series Report, and the relevant Meet the Professor Session topic​ (out of the topics preceded by the letters "MTP"), from the dropdown menu in the abstract submission system. If you choose one of these categories your abstract MAY be considered for case presentation in one of the relevant MTP sessions. ​​​

For additional instructions on how to submit a case to one of the Meet the Professor sessions, please click here. ​

2. Stream​ Preference: 

​Within the abstract submission system, please choose an option from one of the forms below which best describes the nature of your abstract. It is very important that you choose the correct submission form in order for your abstract to be placed in the correct stream. This will allow it to be compared with other similar abstracts and will maximise its chances of selection. It will also affect the information you are asked to provide with your abstract.

  • Clinical Education: Clinical ​Audit or Survey - Methodically collected information on an aspect of clinical care or management.​

  • Clinical Education: A case or Case Series Report (description of one or more cases in order to generate a useful learning experience for clinicians)
  • Clinical Education: Literature Review or Guideline Review - for non-systematic evaluation of important topics in clinical PID
  • Original Science: Clinical trial/study or Basic Science - Empirical data, trials and entirely novel observations (not Formal Systematic Review or meta-analysis). If formal clinical trial please indicate formal trial registration number in abstract. 
  • Original Science:​ Formal Systematic Review or meta-analysis - If formal systematic review please indicate formal systematic review registration number in abstract.   ​

ADDITIONAL REQUIRED INFORMATION 

Before you begin, please prepare the following information:

  • Presenting author’s contact details:
​​Email address
​Full first and family name(s).
Affiliation details: department, institution / hospital, city, state (if relevant), country
​​
  • ​Author and co-authors’ details​
​Full first and family name(s).
​Authors’ names must be in upper and lower case (J.J.C. Smith).
Affiliation details: department, institution / hospital, city, state (if relevant), country

  • Abstract title – limited to 25 words in UPPER CASE
  • Abstract text – limited to 280 words, including acknowledgements. (Please note that each sub-section of your abstract is limited to a specific number of words according to your stream preference). ​
​We recommend using word-processing software (for example, Word) for editing your abstract and counting the number of words.
  • Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word appears the first time.​

  • Use generic names of drugs. Express numbers as numerals.
  • Tables and Images - You are able to add one table/figure per abstract. ​Tables and images can only be placed in certain sub-sections of your abstract, according to your stream preference. The maximum file size of each graph/image is 700 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. You may upload graphs and images in JPEG format only. Please note that images/tables may be resized to fit in the final printed material.​

GUIDELINES FOR SUBMISSION​

  • Abstracts submitted via fax will not be accepted.

  • Submission of an abstract acknowledges your acceptance for the abstract to be published in the official Meeting publications.

  • Presenting authors of abstracts must be registered and paid participants. Registration must be received by the Secretariat by March 15, 2016 to ensure inclusion of the abstract in the Meeting publications and in order to be scheduled for presentation.

  • Abstracts must be original and must not be or have been published or presented at any other meeting prior to the 34th Annual Meeting of ESPID.

  • Abstracts must be submitted in English.

  • After you submit your abstract, you can re-enter the submission link at any time to view and edit your abstract until the deadline date. Submitted abstracts cannot be modified or corrected after the submission deadline. There is no option to save the abstract as draft and to submit it at a later stage. If you do not submit your abstract, the information will be deleted.​

  • ​Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.

  • Please note that consideration will be given to your preferred presentation type, however the final allocation will be determined by the reviewing committee.

  • ​The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission to the Secretariat.

  • ​​ESPID will publish all accepted abstracts online (open access) for a period of at least 5 years. The abstract published online will include the e-mail address of the presenting author. As a condition of submission, ESPID requires you to agree to such publication and to surrender any copyright over the abstract as submitted to ESPID.

  • ​​Abstracts stating “data will be discussed in the presentation” will NOT be accepted.

RULES FOR SUBMISSION

The presenting author is expected to attend the Meeting and present the e-poster or oral presentation. The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission.  Before submitting the abstract, the Abstract Submitter will be required to confirm the following:

  1. ​I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published exactly as submitted.

  2. ​Submission of the abstract constitutes my consent to publication (e.g. Meeting website, programmes, other promotions, etc.)

  3. The Abstract Submitter warrants and represents that he/she is the sole owner or has the rights of all the information and content (“Content“) provided to the 34th Annual Meeting of the European Society for Paediatric infectious Diseases and Kenes International (Hereafter: “The Organisers”). The publication of the abstract does not infringe any third party rights including, but not limited to, intellectual property rights. The Abstract Submitter grants the Organisers a royalty-free, perpetual, irrevocable nonexclusive license to use, reproduce, publish, translate, distribute, and display the Content. 

  4. ​​The Organisers reserve the right to remove from any publication an abstract which does not comply with the above.

  5.  ​​I herewith confirm that the contact details saved in this system are those of the corresponding author, who will be notified about the status of the abstract. The corresponding author is responsible for informing the other authors about the status of the abstract.

​DISCLOSURE

Disc​losure of financial relationships that the author(s) may have with the manufacturer/supplier of any co​mmercial products or services related to the work, should be indicated in the appropriate tick box on the abstract form.

​ABSTRACT SELECTION AND PRESENTATION

All abstracts will be reviewed by the Scientific Programme​ Committee. Presenting authors will be notified via e-mail regarding the status of their abstract acceptance.​​​​

Keep Me Updated